Last reviewed · How we verify

Steroid Containing Mouthwash

Daiichi Sankyo Co., Ltd. · Phase 1 active Small molecule

DS-1062a, a steroid-containing mouthwash developed by Daiichi Sankyo, is currently in Phase 1 clinical trials for advanced solid tumors. Despite no FDA label, the drug shows promise in addressing unmet needs in oncology.

At a glance

Generic nameSteroid Containing Mouthwash
SponsorDaiichi Sankyo Co., Ltd.
ModalitySmall molecule
PhasePhase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: